Shih IM - Search Results

1

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, Wang J, Shah P, Cha SW, Aiyetan P, Woo S, Tian Y, Gritsenko MA, Clauss TR, Choi C, Monroe ME, Thomas S, Nie S, Wu C, Moore RJ, Yu KH, Tabb DL, Fenyö D, Bafna V, Wang Y, Rodriguez H, Boja ES, Hiltke T, Rivers RC, Sokoll L, Zhu H, Shih IM, Cope L, Pandey A, Zhang B, Snyder MP, Levine DA, Smith RD, Chan DW, Rodland KD; CPTAC Investigators. Zhang H, et al. Among authors: shih im. Cell. 2016 Jul 28;166(3):755-765. doi: 10.1016/j.cell.2016.05.069. Epub 2016 Jun 29. Cell. 2016. PMID: 27372738 Free PMC article.

2

Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin.

Shih IM, Torrance C, Sokoll LJ, Chan DW, Kinzler KW, Vogelstein B. Shih IM, et al. Nat Med. 2000 Jun;6(6):711-4. doi: 10.1038/76299. Nat Med. 2000. PMID: 10835692 No abstract available.

3

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.

Chang HW, Lee SM, Goodman SN, Singer G, Cho SK, Sokoll LJ, Montz FJ, Roden R, Zhang Z, Chan DW, Kurman RJ, Shih IeM. Chang HW, et al. J Natl Cancer Inst. 2002 Nov 20;94(22):1697-703. doi: 10.1093/jnci/94.22.1697. J Natl Cancer Inst. 2002. PMID: 12441325

4

Proteomic approaches to tumor marker discovery.

Rai AJ, Zhang Z, Rosenzweig J, Shih IeM, Pham T, Fung ET, Sokoll LJ, Chan DW. Rai AJ, et al. Arch Pathol Lab Med. 2002 Dec;126(12):1518-26. doi: 10.5858/2002-126-1518-PATTMD. Arch Pathol Lab Med. 2002. PMID: 12456215 Free article.

5

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

Singer G, Shih IeM, Truskinovsky A, Umudum H, Kurman RJ. Singer G, et al. Int J Gynecol Pathol. 2003 Jan;22(1):37-41. doi: 10.1097/00004347-200301000-00009. Int J Gynecol Pathol. 2003. PMID: 12496696

6

Increased plasma DNA integrity in cancer patients.

Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW, Shih IeM. Wang BG, et al. Cancer Res. 2003 Jul 15;63(14):3966-8. Cancer Res. 2003. PMID: 12873992

7

HLA-G is a potential tumor marker in malignant ascites.

Singer G, Rebmann V, Chen YC, Liu HT, Ali SZ, Reinsberg J, McMaster MT, Pfeiffer K, Chan DW, Wardelmann E, Grosse-Wilde H, Cheng CC, Kurman RJ, Shih IeM. Singer G, et al. Clin Cancer Res. 2003 Oct 1;9(12):4460-4. Clin Cancer Res. 2003. PMID: 14555519

8

Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors.

Ho CL, Kurman RJ, Dehari R, Wang TL, Shih IeM. Ho CL, et al. Cancer Res. 2004 Oct 1;64(19):6915-8. doi: 10.1158/0008-5472.CAN-04-2067. Cancer Res. 2004. PMID: 15466181

9

Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.

Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL, Shih IeM. Hsu CY, et al. Clin Cancer Res. 2004 Oct 1;10(19):6432-6. doi: 10.1158/1078-0432.CCR-04-0893. Clin Cancer Res. 2004. PMID: 15475429

10

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF, Wang TL, Kurman RJ, Shih IeM. Singer G, et al. Am J Surg Pathol. 2005 Feb;29(2):218-24. doi: 10.1097/01.pas.0000146025.91953.8d. Am J Surg Pathol. 2005. PMID: 15644779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page